应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HDV iShares High Dividend Equity Fun
休市中 12-12 16:00:00 EST
122.96
+0.18
+0.15%
盘后
122.96
+0.00
0.00%
19:51 EST
最高
123.15
最低
122.62
成交量
78.27万
今开
123.00
昨收
122.78
日振幅
0.43%
总市值
120.13亿
流通市值
120.13亿
总股本
9,770万
成交额
9,615万
换手率
0.80%
流通股本
9,770万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
透视瑞博生物赴港之旅:管线布局均衡丰富,具备“中国版Alnylam”稀缺特质
智通财经 · 10-31
透视瑞博生物赴港之旅:管线布局均衡丰富,具备“中国版Alnylam”稀缺特质
世界铂金投资协会:预计2025年铂金市场将出现53.9万盎司的赤字 为连续第三年市场短缺
智通财经 · 2024-12-13
世界铂金投资协会:预计2025年铂金市场将出现53.9万盎司的赤字 为连续第三年市场短缺
美国OTC市场Eiger Biopharmaceuticals, Inc.盘中异动 早盘快速下跌5.88%
市场透视 · 2024-09-27
美国OTC市场Eiger Biopharmaceuticals, Inc.盘中异动 早盘快速下跌5.88%
美国OTC市场Eiger Biopharmaceuticals, Inc.(EIGRQ.us)盘中异动 急速下跌64.71%
市场透视 · 2024-09-19
美国OTC市场Eiger Biopharmaceuticals, Inc.(EIGRQ.us)盘中异动 急速下跌64.71%
加载更多
公司概况
公司名称:
iShares High Dividend Equity Fun
所属市场:
ARCA
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"HDV","market":"US","secType":"STK","nameCN":"iShares High Dividend Equity Fun","latestPrice":122.96,"timestamp":1765573200000,"preClose":122.78,"halted":0,"volume":782669,"hourTrading":{"tag":"盘后","latestPrice":122.96,"preClose":122.96,"latestTime":"19:51 EST","volume":148,"amount":18234.5093,"timestamp":1765587063680},"delay":0,"floatShares":97700000,"shares":97700000,"eps":0,"marketStatus":"休市中","change":0.18,"latestTime":"12-12 16:00:00 EST","open":123,"high":123.15,"low":122.62,"amount":96150730.1162,"amplitude":0.004317,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":122.78,"sharesOutstanding":97700000,"nav":122.987116,"aum":12015841233.2,"dividendRate":0.030755,"bidAskSpread":0.000122,"preHourTrading":{"tag":"盘前","latestPrice":123.5,"preClose":122.78,"latestTime":"09:16 EST","volume":791,"amount":96735.79587,"timestamp":1765548975132},"postHourTrading":{"tag":"盘后","latestPrice":122.96,"preClose":122.96,"latestTime":"19:51 EST","volume":148,"amount":18234.5093,"timestamp":1765587063680},"volumeRatio":0.6805201490507627,"impliedVol":0.0855,"impliedVolPercentile":0.22},"requestUrl":"/m/hq/s/HDV","defaultTab":"news","newsList":[{"id":"2579814485","title":"透视瑞博生物赴港之旅:管线布局均衡丰富,具备“中国版Alnylam”稀缺特质","url":"https://stock-news.laohu8.com/highlight/detail?id=2579814485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579814485?lang=zh_cn&edition=full","pubTime":"2025-10-31 09:08","pubTimestamp":1761872935,"startTime":"0","endTime":"0","summary":"管线布局均衡丰富,核心产品“高价值”释放在即2024年5月31日,全球RNAi疗法龙头Alnylam市值正式超越Moderna,彼时Alnylam的市值约为550亿美元,而Moderna的市值则跌至约530亿美元。从整体布局特点来看,瑞博生物产品管线布局丰富且均衡,核心产品管线主要聚焦在心血管、代谢及肾脏疾病这一类大病种、大市场,商业天花板极高。据悉,2023年12月以来,瑞博生物先后与齐鲁制药、勃林格殷格翰签订合作及许可协议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4081","HDV","BK4585","BK4588","EMA"],"gpt_icon":0},{"id":"2491736712","title":"世界铂金投资协会:预计2025年铂金市场将出现53.9万盎司的赤字 为连续第三年市场短缺","url":"https://stock-news.laohu8.com/highlight/detail?id=2491736712","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491736712?lang=zh_cn&edition=full","pubTime":"2024-12-13 08:54","pubTimestamp":1734051293,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,WPIC铂金投资发文称,预计铂金将在2025年迎来连续第三年的市场短缺。预计2024年铂金总供应量将同比增长2%,达到726.9万盎司。相反,矿产供应预计在2025年将下降13.3万盎司,同比减少2%,因为南非和北美在2024年的重组影响将开始反映在产量中。预计2025年铂金总需求量将下降8.8万盎司,降至786.3万盎司。综合供应疲软与需求低迷,2025年铂金市场仍将出现相当的短缺,预计为53.9万盎司,占需求的7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2023250504.SGD","LU2023250843.SGD","LU0130102774.USD","SGXZ23171101.USD","LU2106854487.HKD","GB00BDT5M118.USD","LU2237957811.SGD","IE00BQXX3F31.USD","BK4551","LU0154236417.USD","LU1917777945.USD","LU0980610538.SGD","LU1153585028.USD","BK4555","LU0154245756.USD","LU2237957902.USD","SG9999004303.SGD","LU0154245673.USD","LU0949170772.SGD","BK4562","BK4149","LU0390134368.USD","BK4585","LU0130517989.USD","LU0256863902.USD","LU1201861249.SGD","LU1974910355.USD","NKLA","IE00BQXX3D17.EUR","BK4112","LU0256863811.USD","LU0648001328.SGD","LU0011850046.USD","BK4588","HDV","LU0477156953.USD","LU0738911758.USD","LU0417517546.SGD","LU0661504455.SGD","IE00BQXX3C00.GBP","ICE"],"gpt_icon":0},{"id":"2470033811","title":"美国OTC市场Eiger Biopharmaceuticals, Inc.盘中异动 早盘快速下跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470033811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470033811?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:18","pubTimestamp":1727450323,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时18分,美国OTC市场Eiger Biopharmaceuticals, Inc.股票出现异动,股价急速下跌5.88%。美国OTC市场Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.70%。美国OTC市场Eiger Biopharmaceuticals, Inc.公司简介:Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司,专注于严重的、罕见的和超罕见疾病的药物的开发和商业化,这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231843ab66870c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231843ab66870c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","PBH","BK4588","BK4007","CHI","EIGRQ","BK4139","BK4123","HDV","PL"],"gpt_icon":0},{"id":"2468508030","title":"美国OTC市场Eiger Biopharmaceuticals, Inc.(EIGRQ.us)盘中异动 急速下跌64.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508030?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:16","pubTimestamp":1726755361,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时16分,美国OTC市场Eiger Biopharmaceuticals, Inc.股票出现波动,股价急速下挫64.71%。美国OTC市场Eiger Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.22%。美国OTC市场Eiger Biopharmaceuticals, Inc.公司简介:Eiger BioPharmaceuticals Inc 是一家商业阶段的生物制药公司,专注于严重的、罕见的和超罕见疾病的药物的开发和商业化,这些药物具有很高的医疗需求并且没有经过批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192216019f0803d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192216019f0803d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","EIGRQ","BK4123","BK4588","HDV","PL","CHI","PBH","BK4585","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://us.ishares.com/product_info/fund/overview/HDV.htm","stockEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0024},{"period":"6month","weight":0.0414},{"period":"1year","weight":0.0553},{"period":"ytd","weight":0.0953}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.004553},{"month":2,"riseRate":0.714286,"avgChangeRate":0.007137},{"month":3,"riseRate":0.714286,"avgChangeRate":0.005163},{"month":4,"riseRate":0.666667,"avgChangeRate":0.017071},{"month":5,"riseRate":0.666667,"avgChangeRate":0.001934},{"month":6,"riseRate":0.466667,"avgChangeRate":-0.003344},{"month":7,"riseRate":0.8,"avgChangeRate":0.017565},{"month":8,"riseRate":0.466667,"avgChangeRate":-0.002404},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.015253},{"month":10,"riseRate":0.533333,"avgChangeRate":0.015506},{"month":11,"riseRate":0.8,"avgChangeRate":0.025417},{"month":12,"riseRate":0.466667,"avgChangeRate":-0.004577}],"exchange":"ARCA","name":"iShares High Dividend Equity Fun","nameEN":"iShares Core High Dividend ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iShares High Dividend Equity Fun(HDV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iShares High Dividend Equity Fun(HDV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iShares High Dividend Equity Fun,HDV,iShares High Dividend Equity Fun股票,iShares High Dividend Equity Fun股票老虎,iShares High Dividend Equity Fun股票老虎国际,iShares High Dividend Equity Fun行情,iShares High Dividend Equity Fun股票行情,iShares High Dividend Equity Fun股价,iShares High Dividend Equity Fun股市,iShares High Dividend Equity Fun股票价格,iShares High Dividend Equity Fun股票交易,iShares High Dividend Equity Fun股票购买,iShares High Dividend Equity Fun股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iShares High Dividend Equity Fun(HDV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iShares High Dividend Equity Fun(HDV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}